Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research and outcome study (RESPIRO)

• Main Authors: Ng, Dorothy Hui Lin, Chia, Travis Ren Teen, Young, Barnaby Edward, Sadarangani, Sapna, Puah, Ser Hon, Low, Jenny Guek Hong, Yan, Gabriel Zherong, Mo, Yin, Ngiam, Nicholas Jinghao, Wang, Samuel Sherng Young, Loo, Yan Tong, Ong, Faith Evangeline Jie Qi, Li, Andrew Yunkai, Ho, Sharlene, Ng, Lisa, Tambyah, Paul Anantharajah, Yeo, Tsin Wen
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2024
• Subjects: Medicine, Health and Life Sciences; Community-acquired pneumonia; Pathogenesis
• Online Access: https://hdl.handle.net/10356/174723
• Institution: Nanyang Technological University

Background: Community-acquired respiratory infections are a leading cause of illness and death globally. The aetiologies of community-acquired pneumonia remain poorly defined. The RESPIRO study is an ongoing prospective observational cohort study aimed at developing pragmatic logistical and analytic platforms to accurately identify the causes of moderate-to-severe community-acquired pneumonia in adults and understand the factors influencing disease caused by individual pathogens. The study is currently underway in Singapore and has plans for expansion into the broader region. Methods: RESPIRO is being conducted at three major tertiary hospitals in Singapore. Adults hospitalised with acute community-acquired pneumonia or lower respiratory tract infections, based on established clinical, laboratory and radiological criteria, will be recruited. Over the course of the illness, clinical data and biological samples will be collected longitudinally and stored in a biorepository for future analysis. Discussion: The RESPIRO study is designed to be hypothesis generating, complementary to and easily integrated with other research projects and clinical trials. The detailed clinical database and biorepository will yield insights into the epidemiology and outcomes of community-acquired lower respiratory tract infections in Singapore and the surrounding region and offers the opportunity to deeply characterise the microbiology and immunopathology of community-acquired pneumonia.